Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$12.7M
Filings
69
Firms Hired
3
Active Period
2009–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
ROCR Value Based Program Act
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: H.R. 2120
Women and Lung Cancer Research and Preventive Services Act of 2025
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: H.R. 2319
Mobile Cancer Screening Act
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: H.R. 4417
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: H.R. 5269
Health Tech Investment Act
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: H.R. 6197
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.
Client expense: $510,000 · Firm income: —
Matched citations: H.R. 8800
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 - issues related to funding for the Food & Drug Administration; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027 - issues related to artificial intelligence and funding for Department of Human Services & National Institutes of Health.
Client expense: $510,000 · Firm income: —
Matched citations: H.R. 9260
Providing for consideration of the bill (H.R. 8646) making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2027, and for other purposes; providing for consideration of the bill (H.R. 7726) to amend the Child Care and Development Block Grant Act of 1990 to withhold funds from noncompliant States under such Act; providing for consideration of the bill (H.R. 7892) to amend the Higher Education Act of 1965 to require to the Secretary of Education to use an identity fraud detection system to review each FAFSA to determine whether the FAFSA presents a reasonable suspicion of identity fraud; and providing for consideration of the bill (H.R. 8872) to amend part A of title IV of the Social Security Act to target funds to low-income families, strengthen program integrity guardrails for State expenditure of funds, require measurement of improper payments, and establish goals for eliminating fraud and improper payments under the program of block grants to States for temporary assistance for needy families, and for other purposes.
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 - issues related to funding for the Food & Drug Administration; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027 - issues related to artificial intelligence and funding for Department of Human Services & National Institutes of Health.
Client expense: $510,000 · Firm income: —
Matched citations: H. Res. 1333
Providing for consideration of the bill (H.R. 8800) to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (H.R. 8595) making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes; providing for consideration of the bill (H.R. 8884) to amend title II of the Social Security Act to reauthorize demonstration authority for the disability insurance program; providing for consideration of the resolution (H. Res. 1383) commemorating the one-year anniversary of the enactment of the Working Families Tax Cuts; and for other purposes.
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.
Client expense: $510,000 · Firm income: —
Matched citations: H. Res. 1398
ROCR Value Based Program Act
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: S. 1031
Women and Lung Cancer Research and Preventive Services Act of 2025
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: S. 1157
Health Tech Investment Act
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: S. 1399
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: S. 2761
Mobile Cancer Screening Act
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 2120 / S. 1031 - ROCR Value Based Program Act; and H.R. 5269 / S. 2761 - RESULTS Act. Proposed Centers for Medicare & Medicaid Services Procedural Notice - Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway. Issues related to Medicare reimbursement rates, including for mobile stroke units and for radiation oncology.
Client expense: $510,000 · Firm income: —
Matched citations: S. 2927
National Defense Authorization Act for Fiscal Year 2027
2026 · third_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 8800 / H. Res. 1398 / S. 4784 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices.
Client expense: $510,000 · Firm income: —
Matched citations: S. 4784
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · third_quarter · Firm: AVENUE SOLUTIONS
Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process; S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: H.R. 5343
Issues related to healthcare data privacy; Issues related to Artificial Intelligence within the healthcare sector; H.R. 6197/S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: H.R. 6197
Issues related to healthcare data privacy; Issues related to Artificial Intelligence within the healthcare sector; H.R. 6197/S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: S. 1399
Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process; S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: S. 1399
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
2026 · third_quarter · Firm: AVENUE SOLUTIONS
Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests; H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process; S. 1399, Health Tech Investment Act
Client expense: — · Firm income: $70,000
Matched citations: S. 1717
ROCR Value Based Program Act
2026 · second_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Client expense: $860,000 · Firm income: —
Matched citations: H.R. 2120
Portable Ultrasound Reimbursement Equity Act of 2025
2026 · second_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Client expense: $860,000 · Firm income: —
Matched citations: H.R. 2477
Mobile Cancer Screening Act
2026 · second_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Client expense: $860,000 · Firm income: —
Matched citations: H.R. 4417
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Client expense: $860,000 · Firm income: —
Matched citations: H.R. 5269
Ensuring Patient Access to Critical Breakthrough Products Act
2026 · second_quarter · Firm: SIEMENS MEDICAL SOLUTIONS USA, INC
H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.
Client expense: $860,000 · Firm income: —
Matched citations: H.R. 5343
Source: Senate LDA